Nathan Eddy
The company will use the funds to scale its technology, expand into new biomarker applications, and advance real-time hydration and metabolic health monitoring.
The collaboration will provide funding, resources and market access to startups developing healthcare technologies expanding into the United States market from the U.K.
The partnership highlights the broader trend of AI-driven innovation in drug discovery and precision medicine.
The acquisition allows Medbridge to expand its AI-enabled body movement analysis offerings for rehabilitation patients.
Through the collaboration, adult men will now have access to Tolmar's testosterone replacement therapy, Jatenzo, via UpScriptHealth's telehealth platform.
The cancer care center will work with AI-enabled spatial computing company Proto Hologram to provide holographic doctor/oncology patient visits.
The organizations will use drones to transport blood samples between Guy’s Hospital and the lab at St. Thomas’ Hospital in London.
The collaboration combines the companies' menopause and virtual care offerings to broaden access to care services for women navigating symptoms of menopause.
The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.
The company's digital therapeutic uses cognitive behavioral therapy to help patients learn techniques to improve their insomnia symptoms.